Long-term follow-up of breast cancer survivors: A randomized controlled study

A randomized controlled study for the long term follow-up of breast cancer survivors: Effect of primary care physician (PCP) coordinated care delivery model on patient-reported outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15403211

Enrollment

1200

Registered

2017-09-06

Start date

2015-02-23

Completion date

Unknown

Last updated

2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer survivorship Cancer Breast cancer

Interventions

The intervention of the study is the PCP-coordinated survivorship program which adopts a multidisciplinary team approach, consisting of physicians, advanced practice nurses (APNs), nurses, social work

Eligibility

Sex/Gender

Female

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 100 2. Female 3. Stage 0,1,2,3 breast cancer 4. Underwent breast cancer surgery within 9 months from enrollment

Exclusion criteria

Exclusion criteria: 1. Other active cancer 2. Renal failure on dialysis 3. Heart failure NYHA class III or IV 4. Cirrhosis Child B or C 5. Severe COPD 6. Active tuberculosis 7. Moderate to severe cognitive dysfunction 8. Any condition resulting in the individual unable to receive breast cancer follow-up care at KF-SYSCC

Design outcomes

Primary

Measure	Time frame
Breast cancer survivor specific quality of life (physical health and mental health) are measured using the Breast Cancer Prevention Trial (BCPT) symptom scale, the Patient Health Questionnaire for depression PHQ9 and anxiety GAD7, and the SF-36 health survey at 6, 12, 18, 24, 30, 36 months after surgery.	—

Secondary

Measure	Time frame
1. Patient satisfaction is measured using a patient satisfaction survey developed for this study at 12, 18, 24, 30, 36 months after surgery 2. Medication adherence is measured using a patient survey developed for this study at 12, 18, 24, 30, 36 months after surgery 3. Cancer recurrence confirmation and serious clinical events are measured using patient survey and by reviewing medical records at 18, 24, 30, 36 months after surgery 4. Healthcare utilization is measured using claims data at the completion of the study 5. Preventive care is measured using patient survey and by reviewing medical records at 18, 24, 30, 36 months after surgery 6. Management of chronic disease is measured using patient survey and by reviewing medical records at 18, 24, 30, 36 months after surgery	—

Measure

Time frame

1. Patient satisfaction is measured using a patient satisfaction survey developed for this study at 12, 18, 24, 30, 36 months after surgery 2. Medication adherence is measured using a patient survey developed for this study at 12, 18, 24, 30, 36 months after surgery 3. Cancer recurrence confirmation and serious clinical events are measured using patient survey and by reviewing medical records at 18, 24, 30, 36 months after surgery 4. Healthcare utilization is measured using claims data at the completion of the study 5. Preventive care is measured using patient survey and by reviewing medical records at 18, 24, 30, 36 months after surgery 6. Management of chronic disease is measured using patient survey and by reviewing medical records at 18, 24, 30, 36 months after surgery

—

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 13, 2026